University of Washington, 1959 NE Pacific St, Box 357120, Seattle, WA 98195, USA.
Boston University, 801 Massachusetts Avenue, Boston, MA 02218, USA.
Contemp Clin Trials. 2021 Feb;101:106257. doi: 10.1016/j.cct.2020.106257. Epub 2020 Dec 26.
Identifying patients with high genetic risk for cancer has important clinical ramifications, but hereditary cancer risk is often not identified because of testing barriers at both the provider and patient level. It is unknown how to best implement appropriate genetic testing and follow-up care into an operating primary care clinic. Implementation studies to date have been conducted in high resourced facilities under optimal conditions, often not at the clinic level. This study aims to compare and evaluate two population-wide engagement strategies for identifying members of a primary care clinic's population with a family or personal history of cancer and offering high-risk individuals genetic testing for cancer susceptibility mutations. The two engagement strategies are: 1) point of care screening (POC), conducted when a patient is scheduled for an appointment and 2) direct patient engagement (DPE), where outreach provides the patient an opportunity to complete screening online on their own time. The study will identify changes, problems, and inefficiencies in clinical flow during and after the implementation of risk assessment and genomic testing for cancer risk across primary care clinics. It will also evaluate the effects of the two engagement strategies on patient, provider, and clinic leader outcomes, including perceptions of benefits, harms, and satisfaction with the engagement strategy and process of cancer risk assessment and genetic testing, across gender, racial/ethnic, socioeconomic, and genetic literacy divides. Finally, the study will evaluate the cost-effectiveness and budget impact of each engagement strategy.
确定具有高癌症遗传风险的患者具有重要的临床意义,但由于提供者和患者层面的检测障碍,遗传性癌症风险通常无法确定。目前尚不清楚如何将适当的基因检测和后续护理最好地纳入常规初级保健诊所。迄今为止,实施研究都是在资源丰富的设施中在最佳条件下进行的,而不是在诊所层面进行。本研究旨在比较和评估两种针对初级保健诊所人群的人群广泛参与策略,以确定有家族或个人癌症史的成员,并为高风险个体提供癌症易感性突变的基因检测。这两种参与策略是:1)即时护理筛查(POC),在患者预约时进行,以及 2)直接患者参与(DPE),通过外展为患者提供一个在自己的时间在线完成筛查的机会。该研究将确定在实施癌症风险评估和基因检测期间和之后,临床流程中的变化、问题和效率低下。它还将评估两种参与策略对患者、提供者和诊所领导的结果的影响,包括对参与策略和癌症风险评估和基因检测过程的益处、危害和满意度的看法,跨越性别、种族/族裔、社会经济和基因素养鸿沟。最后,该研究将评估每种参与策略的成本效益和预算影响。